Artículos originales \ Editorial
Registry-based randomized clinical trials in cardiology: opportunities and challenges
Department of Cardiology, Clinical Sciences, Lund University, Lund, Sweden
REC Interv Cardiol. 2021;3:157-160
The coming convergence of intravascular imaging with computational processing and modeling
aInstitute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States
bDepartment of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States
cCardiovascular Division, Brigham and Women’s Hospital, Boston, Massachusetts, United States
REC Interv Cardiol. 2021;3:161-163
Left atrial appendage occlusion: a decade of evidence
aServicio de Cardiología, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain
bCIBER de Enfermedades Cardiovasculares (CIBERCV), Spain
REC Interv Cardiol. 2021;3:89-90
In search of excellence in transcatheter and surgical aortic valve implantation
Sección de Hemodinámica, Servicio de Cardiología, Hospital Clínico Universitario Virgen de la Arrixaca, El Palmar, Murcia, Spain
REC Interv Cardiol. 2021;3:87-88
FFR post-PCI: what we learned from the FFR-SEARCH study
aDepartment of Cardiology, Catharina Hospital Eindhoven, Eindhoven, The Netherlands
bDepartment of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands
REC Interv Cardiol. 2021;3:83-86
Virtual vs face-to-face meetings. Can both of them coexist?
Servicio de Cardiología Intervencionista, Hospital Universitario de León, León, Spain
REC Interv Cardiol. 2021;3:5-7
Translational research in the new era of percutaneous mitral valve interventions
Cardiovascular Research Foundation, Columbia University Medical Center, New York, NY, United States
REC Interv Cardiol. 2021;3:1-2
Elderly patients with comorbidities and acute coronary syndrome: ¿primum non nocere?
aServicio de Cardiología, Hospital Universitari Son Espases, Institut d’Investigació Sanitària Illes Balears (IdISBa), Palma de Mallorca, Islas Baleares, Spain
bServicio de Cardiología, Hospital de la Santa Creu i Sant Pau, IIB-SantPau, Universitat Autónoma de Barcelona, Barcelona, Spain
cCentro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain
REC Interv Cardiol. 2021;3:3-4
Use of cangrelor in percutaneous coronary interventions: a “new” weapon in the antithrombotic therapeutic armamentarium
aServicio de Cardiología, Hospital Universitario de Bellvitge – IDIBELL, L’Hospitalet de Llobregat, Barcelona, España
bCentro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), España
REC Interv Cardiol. 2020;2:244-246